Arvinas ARVN
NASDAQ ARVN
$6.91 -0.01 (-0.14%)
At close: Nov 11, 2026 · 4:00 PM EST

Arvinas (ARVN) Other financing activities (as filed) (2018 - 2023)

Updated

Arvinas' Other financing activities (as filed) came in at -$15.9 million for Q4 2023.

Analysis

Arvinas (ARVN) Other financing activities (as filed) (2018 - 2023) Analysis & Trends

For FY2023, Arvinas' Other financing activities (as filed) was -$17 million.

  • Going back by year, Other financing activities (as filed) was -$4.6 million in FY2021, -$27.7 million in FY2020 and -$600,000 in FY2019.
  • The Q4 2023 figure represents the highest quarterly Other financing activities (as filed) since Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Arvinas 453.26 Mn -1.97 Bn 400,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -15.90 Mn
Dec 31, 2020 -26.78 Mn
Dec 31, 2019 -600,000.00
Dec 31, 2018 -4.09 Mn
API Access

Arvinas Other financing activities (as filed) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ARVN&period=max&api_key=YOUR_API_KEY